{
    "thread": {
        "uuid": "b48ccbf1ddfacfa7bfdc58043bb93f489b5ddb66",
        "url": "https://www.globenewswire.com/news-release/2024/04/11/2861938/0/en/First-clinical-trial-of-vosoritide-for-children-with-hypochondroplasia-shows-increased-growth.html",
        "site_full": "www.globenewswire.com",
        "site": "globenewswire.com",
        "site_section": "https://www.globenewswire.com/index?page=61",
        "site_categories": [
            "hobbies_and_interests",
            "investors_and_patents"
        ],
        "section_title": "Send Press Releases With GlobeNews Wire | GlobeNewswire",
        "title": "First clinical trial of vosoritide for children with",
        "title_full": "First clinical trial of vosoritide for children with",
        "published": "2024-04-11T03:00:00.000+03:00",
        "replies_count": 0,
        "participants_count": 1,
        "site_type": "news",
        "country": "US",
        "main_image": "https://ml.globenewswire.com/Resource/Download/83f9a7ae-7ee3-4881-a928-1be2c2183408",
        "performance_score": 0,
        "domain_rank": 488,
        "domain_rank_updated": "2024-04-09T13:11:13.000+03:00",
        "reach": null,
        "social": {
            "facebook": {
                "likes": 0,
                "comments": 0,
                "shares": 0
            },
            "gplus": {
                "shares": 0
            },
            "pinterest": {
                "shares": 0
            },
            "linkedin": {
                "shares": 0
            },
            "stumbledupon": {
                "shares": 0
            },
            "vk": {
                "shares": 0
            }
        }
    },
    "uuid": "b48ccbf1ddfacfa7bfdc58043bb93f489b5ddb66",
    "url": "https://www.globenewswire.com/news-release/2024/04/11/2861938/0/en/First-clinical-trial-of-vosoritide-for-children-with-hypochondroplasia-shows-increased-growth.html",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Children's National Hospital",
    "published": "2024-04-11T03:00:00.000+03:00",
    "title": "First clinical trial of vosoritide for children with",
    "text": "WASHINGTON, April 11, 2024 (GLOBE NEWSWIRE) -- Vosoritide’s first global phase 2 study showed an average increased growth rate of 1.8 cm per year in...",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
        "Health",
        "Science and Technology"
    ],
    "external_links": [],
    "external_images": [],
    "entities": {
        "persons": [
            {
                "name": "andrew dauber",
                "sentiment": "none"
            }
        ],
        "organizations": [
            {
                "name": "children’s national hospital",
                "sentiment": "none"
            },
            {
                "name": "children’s national",
                "sentiment": "none"
            },
            {
                "name": "biomarin",
                "sentiment": "none"
            }
        ],
        "locations": [
            {
                "name": "washington",
                "sentiment": "none"
            }
        ]
    },
    "rating": null,
    "crawled": "2024-04-12T02:38:08.779+03:00",
    "updated": "2024-04-12T03:38:27.874+03:00"
}